Clinical trials
Metabolic Syndrome trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 3 |
| 2025 | 4 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Unknown status | 9 |
| Recruiting | 6 |
| Not yet recruiting | 2 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Poznan University of Medical Sciences | 4 |
| Jagiellonian University | 3 |
| Medical University of Bialystok | 2 |
| Medical University of Lodz | 2 |
| Medical University of Warsaw | 2 |
| Poznan University of Life Sciences | 2 |
| Brothers Hospitallers Hospital in Cracow | 1 |
| Collegium Medicum w Bydgoszczy | 1 |
| Gdansk University of Physical Education and Sport | 1 |
| Jarosław Drobnik | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Metabolic Syndrome | 30 |
| Obesity | 11 |
| Overweight | 6 |
| Diabetes Mellitus | 5 |
| Hypertension | 5 |
| Dyslipidemias | 4 |
| Insulin Resistance | 4 |
| Diabetes Mellitus, Type 2 | 3 |
| Glucose Metabolism Disorders | 3 |
| Metabolic Diseases | 3 |
Trials
Showing 26 to 30 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.